Skip to main content
SpringerLink
Log in

Evaluation of Psychosocial Effects of Pre-Symptomatic Testing for Breast/Ovarian and Colon Cancer Pre-Disposing Genes: A 12-Month Follow-Up

  • Published:
Familial Cancer Aims and scope Submit manuscript

Abstract

A prospective study of psychosocial consequences following predictive testing for inherited mutations in breast/ovarian and colon cancer susceptibility genes BRCA1, BRCA2, MLH1, and MSH2 was performed. Eighty-seven healthy women were tested for known family mutations and self-assessment scales were used to evaluate anxiety, depression and quality of life. Extensive pre- and post-test information was given. Questionnaires were responded before testing and four times after during the following year. A statistically significant decrease in anxiety mean scores over time was observed among the studied participants. The levels of depression in cancer genes carriers decreased over time while, surprisingly the levels in non-carriers increased. Compared to a normative Swedish sample all women tested showed similar levels of anxiety but women tested for breast cancer genes showed statistically lower levels of depression. Vitality dropped initially after disclosure of the testing of colon cancer genes carriers, followed by increasing levels. No change in vitality or in other quality of life parameters was seen in the other groups and the levels were similar to Swedish norm data. Most tested individuals were satisfied with the testing procedure including genetic counselling and testing and all of them but one would redo the testing. Healthy self-referred women going through predictive breast/ovarian or colon cancer gene testing, including extensive pre- and post-test information and support, in general, will not experience adverse psychological consequences.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. SOS-1988. National Board of Helth and Welfare. The Cancer Registry. Cancer incidence in Sweden, 1997. Stockholm: Allmänna Förlaget AB, 1997.

    Google Scholar 

  2. Kelsey JL, Gammon MD. The epidemiology of breast cancer. Review. CA Cancer J Clin 1991; 41: 146–65.

    Google Scholar 

  3. Newman B, Austin MA, Lee M et al. Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. Proc Natl Acad Sci USA 1988; 85: 3044–8.

    Google Scholar 

  4. Claus EB, Risch N, Thompson WD. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 1991; 48: 232–42.

    Google Scholar 

  5. Lynch HT, Harris RE, Guirgis HA et al. Familial association of breast/ovarian carcinoma. Cancer 1978; 41: 1543–9.

    Google Scholar 

  6. Hall JM, Lee MK, Newman B et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990; 250: 1684–9.

    Google Scholar 

  7. Miki Y, Swensen J, Shattuck-Eidens D et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66–71.

    Google Scholar 

  8. Wooster R, Neuhausen SL, Mangion J et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994; 265: 2088–90.

    Google Scholar 

  9. Wooster R, Bignell G, Lancaster J et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995; 378: 789–92.

    Google Scholar 

  10. Serova OM, Mazoyer S, Puget N et al. Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancersusceptibility genes? Am J Hum Genet 1997; 60: 486–95.

    Google Scholar 

  11. Peel DJ, Ziogas A, Fox EA et al. Characterization of hereditary nonpolyposis colorectal cancer families from a population-based series of cases. J Natl Cancer Inst 2000; 92: 1517–22.

    Google Scholar 

  12. Lindblom A, Tannergard P, Werelius B et al. Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer. Nat Genet 1993; 5: 279–82.

    Google Scholar 

  13. Peltomaki P, Aaltonen LA, Sistonen P et al. Genetic mapping of a locus predisposing to human colorectal cancer. Science 1993; 260: 810–2.

    Google Scholar 

  14. Burke W, Daly M, Garber J et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. Review. JAMA 1997; 277: 997–1003.

    Google Scholar 

  15. Vasen HF, Haites NE, Evans DG et al. Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinics. European Familial Breast Cancer Collaborative Group. Eur J Cancer 1998; 34: 1922–6.

    Google Scholar 

  16. Eisinger F, Alby N, Bremond A et al. INSERM-FNCLCC collective expertise. Recommendations for medical management of women with genetic risk of developing breast and/or ovarian cancer [in French]. Ann Genet 1999; 42: 51–64.

    Google Scholar 

  17. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361–70.

    Google Scholar 

  18. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale-a review of validation data and clinical results. Review. J Psychosom Res 1997; 42: 17–41.

    Google Scholar 

  19. Sullivan M, Karlsson J, Sjostrom L et al. Swedish obese subjects (SOS)-an intervention study of obesity. Baseline evaluation of health and psychosocial functioning in the first 1743 subjects examined. Int J Obes Relat Metab Disord 1993; 17: 503–5.

    Google Scholar 

  20. Lisspers J, Nygren A, Soderman E. Hospital Anxiety and Depression Scale (HAD): some psychometric data for a Swedish sample. Acta Psychiatr Scand 1997; 96: 281–6.

    Google Scholar 

  21. Sullivan M, Karlsson J. Swedish Manual and Interpretation Guide. International Quality of Life Assessment (IQOLA) Project: Gothenburg Health Care Research Unit, Medical Faculty. Gothenburg, Sweden: Gothenburg University and Sahlgren's Hospital, 1994.

    Google Scholar 

  22. Sullivan M, Karlsson J, Ware JE Jr. The Swedish SF-36 Health Survey-I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sci Med 1995; 41: 1349–58.

    Google Scholar 

  23. Ware JE Jr, Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol 1998; 51: 903–12.

    Google Scholar 

  24. Wagner TM, Moslinger R, Langbauer G et al. Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations. Austrian Hereditary Breast and Ovarian Cancer Group. Br J Cancer 2000; 82: 1249–53.

    Google Scholar 

  25. Watson M, Murday V, Lloyd S et al. Genetic testing in breast/ ovarian cancer (BRCA1) families. Lancet 1995; 346: 583.

    Google Scholar 

  26. Croyle RT, Smith KR, Botkin JR et al. Psychological responses to BRCA1 mutation testing: preliminary findings. Health Psychol 1997; 16: 63–72.

    Google Scholar 

  27. Broadstock M, Michie S, Marteau T. Psychological consequences of predictive genetic testing: a systematic review. Eur J Hum Genet 2000; 8: 731–8.

    Google Scholar 

  28. Kash KM, Holland JC, Halper MS et al. Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst 1992; 84: 24–30.

    Google Scholar 

  29. DudokdeWit AC, Tibben A, Duivenvoorden HJ et al. Predicting adaptation to presymptomatic DNA testing for late onset disorders: who will experience distress? Rotterdam Leiden Genetics Workgroup. J Med Genet 1998; 35: 745–54.

    Google Scholar 

  30. Meiser B, Halliday JL. What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer? A meta-analytic review. Soc Sci Med 2002; 54: 1463–70.

    Google Scholar 

  31. Lerman C, Biesecker B, Benkendorf JL et al. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. J Natl Cancer Inst 1997; 89: 148–57.

    Google Scholar 

  32. Schwartz MD, Peshkin BN, Hughes C et al. Impact of BRCA1/ BRCA2 mutation testing on psychologic distress in a clinic-based sample. J Clin Oncol 2002; 20: 514–20.

    Google Scholar 

  33. DiCastro M, Frydman M, Friedman I et al. Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information.AmJMed Genet 2002; 111: 147–51.

    Google Scholar 

  34. Butow PN, Lobb EA, Meiser B et al. Psychological outcomes and risk perception after genetic testing and counselling in breast cancer: a systematic review. Med J Aust 2003; 178: 77–81.

    Google Scholar 

  35. Aktan-Collan K, Mecklin JP, Jarvinen H et al. Predictive genetic testing for hereditary non-polyposis colorectal cancer: uptake and long-term satisfaction. Int J Cancer 2000; 89: 44–50.

    Google Scholar 

  36. Esplen MJ, Madlensky L, Butler K et al. Motivations and psychosocial impact of genetic testing for HNPCC. Am J Med Genet 2001; 103: 9–15.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular Medicine, Clinical Genetic Unit, Karolinska University Hospital, Stockholm, Sweden

    Brita Arver, Aina Haegermark, Ulla Platten & Annika Lindblom

  2. Department of Oncology and Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden. Tel:

    Brita Arver & Yvonne Brandberg

Authors
  1. Brita Arver
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aina Haegermark
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ulla Platten
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Annika Lindblom
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yvonne Brandberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arver, B., Haegermark, A., Platten, U. et al. Evaluation of Psychosocial Effects of Pre-Symptomatic Testing for Breast/Ovarian and Colon Cancer Pre-Disposing Genes: A 12-Month Follow-Up. Familial Cancer 3, 109–116 (2004). https://doi.org/10.1023/B:FAME.0000039863.89137.f9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:FAME.0000039863.89137.f9

Search

Navigation